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Cytochrome P-450 (P-450) and associated mono-oxygenase activities were estimated in male and female rat brain microsomes. The P-450 
concentration i male rat brain was one-tenth the corresponding hepatic levels, which is considerably higher than earlier reports. A distinct 
sex-related ifference was observed in the levels of total P-450 and mono-oxygenase activities known to be mediated by P-450b,c; the female 
brain levels were 60% of those in the males. Immunoinhibition and immunoblot studies using antisera to P-450b. c and P-450c. a indicated the 
presence of multiple forms of P-450, immunologically similar to P-450b. e,P-450 cand P-450 din the rat brain. Prior treatment with phenobarbital 
resulted in two-fold increase of total P-450 and selective induction of aminopyrine N-demethylase (APD) and morphine N-demethylase (MND) 
activities. Administration of 3-methylcholanthrene, selectively induced the levels of ethoxycoumarin O-deethylase (ECD) and arylhydrocarbon 
hydroxylase, although the levels of total P-450 were not increased. 3-Methylcholanthrene i duction was also accompanied by a shift in the 
absorption maximum of the reduced carbon monoxide difference spectrum from 452 to 448 nm. Immunocytochemical localization using 
antibodies to P-450b. c indicated the presence of P-450 predominantly in the neuronal cell bodies and to a lesser extent in the fibre tracts in 
cerebral cortex, cerebellum, thalamus, hypothalamus, hippocampus and brainstem. These studies indicate that the brain contains ignificant 
amounts of P-450, which exists in multiple forms and can be selectively induced by prior exposure to phenobarbital or 3-methylcholanthrene. 
Cytochrome P-450 (P-450) containing mono-oxyge- 
nases is involved in the biotransformation of foreign 
compounds (drugs and environmental toxins) and en- 
dogenous compounds (steroids, eicosanoids etc.). Gen- 
erally, xenobiotic metabolism mediated through P-450 
leads to the formation of hydrophillic, non-toxic metab- 
olites, that are easily excreted from the body. However, 
there are several instances wherein an inert, non-toxic 
compound is converted to a reactive, toxic metabolite 5. 
Although liver is the primary organ involved in P-450 
mediated metabolism, recent advances in toxicology have 
demonstrated the importance of extrahepatic P-450 in 
target organ toxicity. Cerebral P-450 could have a 
multifunctional role in the metabolism of steroids and 
local pharmacological modulation of drugs acting on the 
central nervous system. Further, considering the limited 
regenerative capability of the CNS, bioactivation of 
xenobiotics in situ within the brain could have far 
reaching consequences in causing neoplastic transforma- 
tion or disruption of neuronal function 1°. 
Recent studies have implicated a causative role for 
environmental toxins in the etiopathogenesis of certain 
neurodegenerative disorders, and the vulnerability of the 
CNS to damage through toxicants 2'7'17. In view of this, 
bioactivation and detoxification of environmental toxins 
by cerebral P-450 may be important. 
The presence of P-450 in rat brain microsomes was 
demonstrated and reported to be only 3-3.6% of the 
hepatic levels 16. The P-450-associated mono-oxygenases 
in the brain have also been reported to be present in low 
concentration 3,6,8,n,19. 
Recent studies from our laboratory have demonstrated 
that although the total P-450 levels in the mouse brain 
were very low (~4% of hepatic levels), the concentration 
of certain P-450-associated mono-oxygenase activity was 
considerably higher in mouse brain as compared to the 
corresponding hepatic levels 13. Determination of P- 
450-associated mono-oxygenase activity in brain and liver 
from human autopsy samples also revealed that the 
specific activity of morphine N-demethylase in the brain 
was higher than the hepatic levels in the same indi- 
vidual 14. 
We now report investigations on rat brain P-450, the 
presence of multiple forms of P-450, their inducibility and 
immunological similarity to rat liver P-450. 
Wistar rats (3 months old) from the stock colony of the 
institute were used for all experiments. Brain and liver 
microsomes were prepared from 10 rats for each experi- 
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ment and the purity was ascertained as described ~2. 
P-450 levels were measured by the method of 
Matsubara 9, with certain modifications 4. NADPH cyto- 
chrome c reductase, 7-ethoxycoumarin O-deethylase 
(ECD), benzo(a)pyrene hydroxylase (BPH), aminopy- 
rine N-demethylase (APD) and morphine N-demethylase 
(MND) activities were estimated as described 4. Protein 
was determined by the dye-binding method 1. 
Two forms of hepatic P-450 were purified to apparent 
homogeneity from phenobarbital (P-450b,e) and 3- 
methyl-cholanthrene (P-450¢) treated rats a. The specific 
contents were 13 nmoles of P-450/mg protein for each of 
the purified forms. Antibodies were raised in rabbits to 
both the purified forms of P-450. No cross-reactivity was 
observed between P-450b, e and P-450~. However, the 
antisera raised to P-450 c exhibited immunological cross- 
reactivity to P-450a and hence this antisera is referred to 
as anti-P-450~, d. SDS-polyacrylamide g l electrophoresis 
of microsomal proteins was carried out and the proteins 
were transferred to nitrocellulose sheets and immuno- 
stained as described ~3. 
In order to determine the induction of cerebral P-450, 
phenobarbital (80 mg/kg b. wt.) was given i.p. for 10 days 
and rats were sacrificed 24 h after the last dose. 
3-Methylcholanthrene (3-MC), (45 mg/kg b. wt.) was 
administered s.c. for 4 days and rats were sacrificed 24 h 
after the last dose and the microsomes were prepared 
from brain and liver as described earlier ~2. Rat brain 
sections were processed for immunocytochemistry using 
antisera to P-450b,e 14. 
The content of P-450 and associated mono-oxygenase 
activities in rat brain and liver microsomes is given in 
Table I. The male rat brain P-450 content was one-tenth 
of the corresponding hepatic levels. A distinct sex-related 
difference was observed; the female rat brain P-450 levels 
were significantly lower than the male brain levels. This 
difference was also reflected in the activities of APD and 
MND; the concentration of the enzyme in the female rat 
brain was only 49 and 51%, respectively, of the levels in 
male rat brain. Further, the specific activity of these 
enzymes was significantly higher in the male rat brain as 
compared to the hepatic levels. ECD and BPH activities 
did not exhibit any sex-related difference and their 
concentration in the brain was significantly lower than 
the hepatic levels. NADPH cytochrome c reductase level 
in the rat brain was 30% of the hepatic levels. Treatment 
with phenobarbital for 10 days resulted in a two-fold 
induction of total P-450 as compared to untreated 
controls (Table I). The sex-related ifference was signifi- 
cant in phenobarbital-induced animals also. Following 
treatment with phenobarbital, both APD and MND 
activities were induced, while ECD activity was not 
significantly different from the controls. The NADPH 
TABLE 1 
Cytochrome P-450 and associated rnono-oxygenase activities in ral 
brain and liver microsomes 
Activities are represented as (a) nmoles of cytochrome P-450/mg 
protein, (b) nmoles of product formed/mg protein/min and reductasc 
(NADPH cytochrome c reductase) is expressed as nmoles of 
cytochrome c reduced/mg protein/min. Values are means -+ S.D. of 3 
experiments. ND, not determined. 
Brain L iver 
Male Female Male Female 
P-450 ~ 
Control 0.09+0.005 0.05+0.004 0.86+0.02 0.63+0.03 
PB 0.17+0.01" 0.10+0.01" 2.12_+0.05" 1.39_+0.04" 
3-MC 0.09+0.01 ND 1.00_+0.14 ND 
BPH h 
Control 0.01 +0.001 0.01-+0.002 1.78+0.02 1.61+_0.05 
3-MC 0.02+0.003* ND 4.01-+0.52" ND 
ECD t' 
Control 1.5+0.3 1.6+0.4 6.5+1.2 5.4+1.3 
PB 1.17+0.25 1.11+0.19 5.2+0A9 5.3+0.5 
3-MC 3.5_+0.42* ND 12.75+1.06" ND 
A PD b 
Control 174.3-+19.8 85.3-+24.9 107.3+17~8 1.1+14.1 
PB 374.1-+37.5" 188.2+31.9" 317.8+20A* 223.2+-27.3* 
3-MC 150.3+9.2 ND 120.2+2.4 ND 
MND b 
Control 128.7+-9.6 66.2+10.9 74.1+8.7 55.9+-4.3 
PB 244.0+29.0* 124.7+12.6" 217.9-+25.9" 159.6+12.6" 
Reductase 
Control 21.3_+2.4 23.3+2.8 74.6-+22.0 68.6+_2.9 
PB 57.4+4.6* 55.9+8.6* 265.0+ 16.97" 269.0_+52.3* 
* Indicates values ignificantly different (P < 0.001) from respective 
untreated control. 
cytochrome c reductase activity was also induced in the 
brain following phenobarbital treatment. Administration 
of the condensed aromatic hydrocarbon, 3-MC, did not 
result in the elevation of total P-450 levels in the male rat 
brain, although the ECD and BPH activities were 
selectively and significantly increased (233 and 182%, 
respectively). No sex-related ifference was seen (data 
not shown). The absorbance maximum of the reduced 
carbon monoxide difference spectrum of brain micro- 
somes from control rats was observed at 452 nm. 
Following treatment with phenobarbital, the absorption 
maximum shifted to 450 nm, while 3-MC treatment 
resulted in the shift to 448 nm. These results indicate the 
preferential induction of specific forms of P-450. The 
activity of brain P-450-mediated mono-oxygenases was 
dependent on the presence of oxygen and NADPH,  and 
was significantly inhibited by carbon monoxide and 
specific inhibitors of P-450, namely, piperonyl butoxide 
and SKF 525A (data not shown). 
SDS-PAGE of rat brain and liver microsomal proteins, 
followed by immunoblotting with antisera to P-450b,e, 
revealed the presence of a single protein band in both 
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Fig. 1. Immunoblots of rat brain and liver microsomes following 
staining with antisera to (A): P-450b.e and (B): P-450c.d. A: the lanes 
contained (1) purified P-450b, c antigen [4/zg], (2) female rat brain 
microsomes [42/~g], (3) female rat liver microsomes [7.5 #g], (4) 
male rat brain microsomes [34/~g] and (5) male rat liver microsomes 
[7.5/~g]. B: the different lanes contained (1) purified P-450 cantigen 
[5 pzg], (2) untreated rat brain microsomes [80/~g], (3) 3-MC treated 
male rat brain microsomes [55/~g], (4) 3-MC treated male rat liver 
microsomes [10/zg] and (5) untreated male rat liver microsomes (25 
/zg]. The protein concentration is given in parentheses. 
brain and liver microsomes. This band co-migrated with 
purif ied P-450b, e (Fig. 1A). Addit ion of 100/~1 of antisera 
resulted in significant inhibition of APD and MND (85% 
and 61%, respectively) activity as compared to micro- 
somes treated with preimmune serum. However,  ECD 
activity was only partial ly inhibited (29%) by the same 
antisera (data not shown). Immunoblot analysis of rat 
brain and liver microsomes using the antisera to P-450c,d 
is depicted in Fig. lB.  Purif ied P-450 c exhibited a single 
band. In the liver and brain microsomes two bands, 
corresponding to P-450 c (which co-migrated with purified 
P-450¢) and P-450u, were observed. Pretreatment with 
3-MC resulted in the induction of these forms in the brain 
Fig. 2. Immunocytochemical localization of P-450 in the male rat 
brain using antisera to rat liver P-450b, e. A: immunoreactive 
neurons of the cerebral cortex. Note the reduced staining of the 
lower layers of the cortex. (x 122). B: immunoreactive n uronal cell 
bodies in the thalamus and posterior hypothalamus (dark arrow). 
Note the relative paucity of staining in the white matter (x49). C: 
higher magnification of the area marked by arrow in (B), showing 
immunoreactive n uronal somata of the posterior hypothalamus 
(x182). D: strong immunostaining of the large neurons and 
processes of the mesencephalic trigeminal nucleus. There is lack of 
staining of the adjacent small neurons (x 160). 
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and liver microsomes (Fig. 1B). The activity of ECD was 
almost completely inhibited (83.5%) by the antisera to 
P-450c,d, while APD activity was inhibited only partially 
(49%) by the same antisera (data not shown). 
lmmunohistochemical localization of P-450 using an- 
tibodies to P-450b, e revealed robust staining of the 
neuronal cell bodies; the staining of the white matter was 
considerably less. The staining of the white matter was 
better discernable in the compactly arranged fibre tracts 
(Fig. 2). The neuronal somata of the cerebral cortex (Fig. 
2A), the thalamus (Fig. 1B), the hypothalamus (Fig. 2B 
and 2C), and the brainstem (Fig. 2D) revealed significant 
immunoreactivity. In the cerebellum, the vermis showed 
variable staining of the Purkinje cells and glial elements. 
In the brainstem, the neurons of the mesencephalic 
trigeminal nucleus (Fig. 2D), the large reticular neurons 
and some of the cranial nerve nuclei revealed strong 
immunoreactivity. The neuronal somata of the spinal 
grey horn cells also showed variable staining. 
The P-450 levels in the rat brain have been reported to 
be 3-3.6% of the hepatic levels (36 picomoles of 
P-450/mg protein) ~6. However, using stringent conditions 
for isolation of microsomes, much higher levels of P-450 
( -85 pmoles/mg protein) were detected. In an earlier 
report 19, partial purification of rat brain homogenate has 
been carried out to determine P-450 levels from the 
reduced carbon monoxide difference spectrum. How- 
ever, since the brain mitochondrial P-450 content is 
reported to be significantly high TM (and as observed by 
us), estimation of P-450 in total brain homogenate would 
include contribution from both microsomal and mito- 
chondrial P-450. 
Although cerebral P-450 level was determined to be 
only one-tenth of the hepatic level, APD and MND 
activities in the male brain were significantly higher than 
in the male liver (Table I). Thus, the brain may possess 
considerable metabolizing capability for certain sub- 
strates. A distinct sex-related ifference was observed in 
P-450 levels and APD and MND activities (Table I). In 
the rat liver, it has been demonstrated that sex-related 
differences exist in the constitutive forms of P-450 b and 
P-450e 2°. 
Although the APD and MND activities were higher in 
the brain as compared to liver, ECD activity was only 
23% of hepatic activity. The BPH activity in brain was 
particularly low, being only 0.56% of the corresponding 
hepatic levels. No sex-related ifference was observed in 
cerebral ECD and BPH activities, which are induced by 
3-MC treatment. 3-MC inducible forms of P-450 in rat 
liver, namely, P-450~ and P-450d do not exhibit a 
sex-related ifference 5.
The presence of multiple forms of P-450 in rat brain is 
demonstrated by the selective inhibition of mono-oxyge- 
nase activity by antisera to different forms of rat liver 
P-450. Thus, the brain APD activity is inhibited to a 
greater extent by the antisera to P-450b,e, while ECD 
activity is inhibited almost completely by the antisera to 
P-450c,d. These results eem to indicate that the APD and 
ECD activities are mediated by different forms of P-450 
in the rat brain. This is further substantiated by the 
immunoblot experiments, where multiple forms were 
detectable in the brain. The presence of multiple forms 
of P-450 was also demonstratable by the differential 
induction of various mono-oxygenase activities by phe- 
nobarbital and 3-MC. While ECD and BPH activities 
were induced by 3-MC treatment, APD and MND 
activities were induced following administration of phe- 
nobarbital (Table I). The present results demonstrate he 
presence of multiple forms of P-450 in the rat brain which 
are immunologically similar to the rat liver P-450h.~ and 
P-450c and P-450d. 
Immunohistochemical studies using antibodies to P- 
450b,e revealed the localization of the enzyme, essentially 
in the neuronal cell bodies and to a lesser extent in the 
white matter. The intense staining of the large reticular 
neurons in the brainstem, revealed a pattern of staining 
similar to that seen in the human brain TM. The immuno- 
histochemical localization of NADPH cytochrome P-450 
reductase, an essential component of the P-450 mono- 
oxygenase system, in brain 15, has revealed the co- 
localization of the P-450 and NADPH cytochrome P-450 
reductase. 
The present study demonstrates that the rat brain does 
indeed contain significant amounts of P-450 and high 
concentration of certain P-450 mediated mono-oxyge- 
nases. P-450 exists in multiple forms in the rat brain 
which are selectively induced and localized predomi- 
nantly in the neurons. The induction of selective mono- 
oxygenase activity in the brain by phenobarbital would 
have far reaching implications in pharmacological mod- 
ulation of drugs in combination drug therapy, since 
phenobarbital is a commonly used anti-convulsant. Fur- 
ther, the induction of certain cerebral P-450-mediated 
mono-oxygenases by 3-methylcholanthrene i dicates that 
continued exposure to environmental pollutants could 
result in increased bioactivation or detoxification of 
environmental toxins and drugs which are metabolized by 
this form of P-450. 
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